A NEW ERA OF PATHOLOGY
AI-powered precision
diagnostics for Pathology
Decoding pathology for personalized treatments
We believe that AI holds the key to discover the next generation of tissue-based biomarkers to drastically improve how cancer and other complex diseases are diagnosed and treated. Our mission is to support the discovery and validation of these biomarkers, and to develop them into diagnostic products for global use in clinics and labs.



We uniquely combine data, tech and pathologists
Our AI models are trained with clinical-grade data from multiple leading German institutes, and are developed side-by-side with experienced pathologists.
A patented “Explainable AI” approach allows us to overcome conventional “black box” limitations of end-to-end AI models. A proprietary cell detection and classification approach enables us to dig deep into morphology and immune responses.
What we do
We are an interdisciplinary team of machine learners, data scientists, pathologists, biologists, software engineers, regulatory experts and business professionals, focused on three areas:

Research
We develop novel algorithms for use in pre-clinical and translational research, on our own data. Our focus lies on assessing complex structures and cell types with AI in H&E, IHC and multiplex IF, in combination with clinical, molecular and proteomics data.

Clinical trials
We build robust IVDR-compliant AI models from multi-lab data, for H&E, IHC and multiplex IF. We work in close collaboration with pathologists from Charité and other leading institutes, as well as regulatory experts, and can deploy with our own platform.
